For patients with muscle-invasive urothelial carcinoma, an oncology trial has shown promising results.

Published Date: 31 Jan 2024

A novel treatment option may be available to patients with muscle-invasive urothelial cancer who have a high risk of recurrence following surgery. Results from the Phase III AMBASSADOR have been declared positive by the Alliance for Clinical Trials in Oncology.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot